Express Pharma
Browsing Category

Editor’s Note Archive

Playing the frenemy card

AIDAN’s PIL accusing the DoP of 'browbeating' the NPPA might not be so far-fetched as innovators and generic companies cosy up…

Adding bite to DCG(I)’s bark

On August 6, the quality assurance (QA) division of the CDSCO had released guidelines on the procedures to be followed by its…

The Ebola effect

The fear of the Ebola Virus Disease (EVD) being imported into India is worrying our Parliamentarians but besides relying on…

India’s loss, China’s gain?

India's drug pricing authority, the National Pharmaceutical Pricing Authority is once again at loggerheads with the industry

Wish upon on a star

Narendra Modi's massive electoral mandate has unfortunately raised expectations; both from the man on the street as well as from…

Riding the wave

Across industries, hopes are riding high on the Modi government

No easy wins in pharma

As we go to press, the Pfizer-AstraZeneca deal is called off for now but that story is far from over

Three more cos face US FDA ire-1

Last month, the US FDA has reportedly issued 483s to at least three more pharmaceutical companies in India, one of them the Indian…

Bitter medicine

Name-Shame-Blame-Train. This has been the pharmaceutical industry's mantra to manage non-compliance

Raising the bar

After visiting the Taj Mahal on her recent visit to India, FDA Commissioner Margaret A Hamburg blogged, “those responsible for…

Recruiting right

Blogging about her recent trip to India, Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA) spoke about…

In search of greener pastures

After hanging fire for the past few months, the Department of Industrial Policy and Promotion (DIPP) has finally given some…